Key result
In dogs with acute myocardial infarction, dobutamine reduced infarct size to 55% of the risk zone compared to 76% with dopamine or control.
Why the study?
Does dobutamine compared to dopamine improve hemodynamics and reduce infarct size in a canine model of acute myocardial infarction?
Does dobutamine compared to dopamine improve hemodynamics and reduce infarct size in a canine model of acute myocardial infarction?
In a canine model of acute MI, dobutamine reduces infarct size and maintains positive inotropic effects at 24 hours, whereas dopamine does not, likely due to dopamine-induced local myocardial release of norepinephrine.
Answers are grounded in this paper and cite their sources.
Should not change acute MI care; leaves open whether dobutamine's infarct-sparing effect translates to patients.
To compare cardiovascular effects of dobutamine and dopamine, we administered the two agents at a dose of 10 gpg/kg/min i.v. to two groups of chronically instrumented conscious dogs, beginning 40 minutes after coronary artery occlusion and continuing for 24 hours thereafter.A control group that was given an infusion of 5% dextrose was also studied.During the first 30 minutes of infusion, both dobutamine and dopamine produced similar increases in cardiac output, left ventricular dP/dt and dP/dt/P, without significant changes in heart rate, mean arterial blood pressure or regional myocardial blood flow.At 24 hours, cardiac output and left ventricular dP/dt and dP/dt/P continued to be greater in the dobutamine group than in the control group.The acute positive inotropic effects of dopamine were no longer apparent at 24 hours.Epicardial blood flow in the dobutamine-treated group also was higher than that in the control group.There were, however, no differences between groups in the ischemic-to-nonischemic myocardial blood flow ratio.In addition, infarct size, measured by nitroblue tetrazolium staining, was smaller in the dobutamine group (55 ± 4% of risk zone) than in the dopamine group (76 ± 6%) or the control group (76 + 5%).The dobutamine group also differed from the dopamine group in their plasma catecholamine levels.Arterial plasma concentrations of norepinephrine and epinephrine increased above the postocclusion baseline values only during dopamine infusion by 1.50 ± 0.34 and 0.87 0.32 ng/ml, respectively.Dopamine also caused myocardial release of norepinephrine, as evidenced by a significant transmyocardial gradient (coronary sinus minus arterial difference) of 1.48 + 0.27 ng/mI.The results show that dobutamine increases collateral flow to the ischemic myocardium, enhances left ventricular performance, and reduces infarct size.None of these effects were produced by dopamine under these experimental conditions.The difference between the effects of the two drugs probably is related, at least in part, to the detrimental effects of local myocardial release of norepinephrine by dopamine.DOBUTAMINE is a cardioselective adrenergic agent that augments myocardial contractility, cardiac output and myocardial blood flow with only minimal changes in heart rate or arterial blood pressure.'-5It may be used clinically to improve depressed cardiac function with- out further impairment of oxygen balance or metabo- lism of the ischemic heart.6`Dobutaminenot only improves the global performance of the heart, but also reduces infarct size during acute experimental myocardial infarction.9These salutary effects probably are causally related to the increase in ischemic myocardial blood flow produced by dobutamine.However, Tut- tle'0 showed that a reduction of myocardial necrosis by dobutamine was accompanied not only by an increase in myocardial blood flow, but also by a reduction in the amount of norepinephrine released from cardiac sympathetic fibers that was facilitated after myocardial ischemia.Local release of excessive endogenous norepinephrine is generally thought to be injurious to is-
No takes yet. Share an insight, caveat, or question.
Maekawa et al. (1983) studied Acute myocardial infarction. Dobutamine vs. Dopamine and 5% dextrose control was evaluated on Infarct size (% of risk zone). In dogs with acute myocardial infarction, dobutamine reduced infarct size to 55% of the risk zone compared to 76% with dopamine or control.
Synapse has enriched 10 related papers. Consider them for comparative context: